Llewellyn King

Llewellyn King
Location
Washington, District of Columbia, USA
Birthday
October 06
Title
Executive Producer and Host
Company
White House Chronicle TV
Bio
Llewellyn King is the creator, executive producer and host of “White House Chronicle,” a weekly news and public affairs program, airing nationwide on more than 200 PBS and public, education and government access stations, and worldwide on Voice of America Television. Now in its 15th year on the air, the program can also be viewed on the Web at whchronicle.com. An audio version of the program airs on Sirius XM Satellite Radio’s POTUS Channel 124. In addition, King writes a weekly column for the Hearst-New York Times Syndicate. In 2006 University Press of America published a collection of his columns, entitled “Washington and The World 2001-2005,” which mainly appeared in Knight-Ridder newspapers, including The Miami Herald, The Sacramento Bee, The St. Paul Pioneer Press, The Kansas City Star, The Charlotte Observer and The Columbus Dispatch. King was the founding editor in chief and publisher of The Energy Daily. The iconic energy industry newsletter, created before the energy crisis broke out in 1973, was the flagship of his King Publishing Group, whose other award-winning titles included Defense Week, New Technology Week, Navy News & Undersea Technology and White House Weekly. King's insightful reporting and analysis of energy led to frequent guest spots on television news shows, including “Meet the Press” and “The NewsHour with Jim Lehrer.” King's remarkable career in journalism began in Southern Rhodesia, now Zimbabwe, where he was hired at age 16 as a foreign correspondent for Time magazine. He also reported from Africa for London's Daily Express and News Chronicle and United Press. Moving to London in 1959, King worked as an executive for The Daily Mirror Group, a reporter for Associated Newspapers, and a news writer for BBC and ITN. After moving to the United States, King worked as an editor and reporter for many top newspapers, including The New York Herald Tribune, The Baltimore News-American, The Washington Daily News and The Washington Post. While working at The Washington Post, he headed the Washington-Baltimore Newspaper Guild. A stint at McGraw-Hill's Nucleonics Week led to his founding The Energy Daily. But The Energy Daily was not King's first ahead-of-its-time publication. His first was Women Now, a monthly magazine targeted to emerging professional women in the 1960s. “It didn’t liberate any women, but it liberated all my money,” King says. Before creating “White House Chronicle,” King hosted “The Bull and The Bear,” a daily stock market program that aired on the GoodLife and Jones cable television networks in the mid-1990s. King has given more than 2,000 speeches. He continues to be an in-demand and erudite commentator on energy, foreign affairs, Congress, the White House, small business, and science and technology. He has organized more than 1,000 conferences on issues ranging from nuclear energy to land mine removal to Social Security to campaign finance.

MY RECENT POSTS

Llewellyn King's Links

Salon.com
NOVEMBER 21, 2011 11:59AM

Chronic Fatigue Syndrome: The Silent Suffering

Rate: 2 Flag

By Llewellyn King

In the world of chronic illness, there is hope and false hope; well-founded hope and dashed hope. New therapies, real or rumored, lift the spirits of the desperately sick before they are brought crashing down, when science comes up empty-handed -- such as when a controlled study fails to confirm a cure, or even the path to a cure.

This is what has happened this year to "the silent many" --  people who suffer from Chronic Fatigue Syndrome (CFS), also known as myalgic encephalomyelitis. Silent because of all the big diseases, it is probably the least publicized, least talked about, and the most ignored in medical institutions -- the institutions charged with protecting the public health. There are an estimated 1 million CFS sufferers in the United States, and another 16 million worldwide.

As AIDS was initially, CFS is haunted by fear, stigma and ignorance. It is misdiagnosed and often its victims are abused, thrown out of their families, and live in squalor and pain with little hope. They despair that they cannot convince doctors, their families or their loved ones that they are, in fact, sick.

There is no cure for CFS,  just a lot of conflicting theory. There is nothing on the pharmacists’ shelves to relieve their suffering. Nothing.

There are also powerful economic and institutional forces that have conspired to keep CFS in the shadow; in that world of anguish, where the victims feel they are to blame because they are a burden to those who love them. The costs of care are crushing.

What is known is that CFS is a disease of the immune system; that it is reported among women by 3-to-1; that it has no cure -- no certain day when the monster will leave the sick bed. It ebbs and flows in cycles -- good days and bad days, good years and bad years. People who suffer say it confiscates their lives. There are terrible periods when one is so sick that one is bedridden for months or years.

Most doctors are not qualified to offer CFS diagnoses, confusing it with other conditions. The rural poor are almost entirely on their own. Suicide is common, according to Marly Silverman, a sufferer who heads an umbrella group that calls itself Pandora.

This year has been a mixed year for hope in the CFS community: A whole line of research has been dashed, and with it a lot of accumulated hope.

Some researchers -- particularly those at the privately funded Whittemore Peterson Institute in Reno, Nev. -- had spent great effort in pursuit of a retrovirus, XMRV. The institute, and its scientific allies, had believed that XMRV was the culprit and that if this could be proven beyond doubt, then there would be a basis to develop an antiviral agent to arrest the disease. But separate studies in the United States and Britain have undermined the XMRV hypothesis, leaving the hopeful bereft.

At the same time the use of an experimental drug, Ampligen, is helping a patient elite of about 750: They can get the drug in limited trials and can expect to pay between $25,000 and $40,000 a year for it. Ampligen's manufacturer is a small company, Hemispherx, which has to charge its trial subjects. Unlike large drug companies, Hemispherx cannot administer Ampligen in trials for free, and it needs much more clinical data before it can get full Food and Drug Administration approval.

Ampligen bolsters the immune system: While being treated with the drug, patients report an abatement of symptoms, greatly improving the quality of their lives.

Now comes extraordinary news out of Norway, where a drug developed for Non-Hodgkin’s lymphoma , Retuxin, has produced gratifying results. A Bergen hospital study of CFS patients taking Retuxin found 67 percent reporting good recovery and sometimes full recovery. One patient, a young girl, went from being bedridden to skiing and a full athletic life.

Retuxin suppresses a portion of the B-cells among sufferers, suggesting that it is rearranging the immune system by correcting imbalances in its function.

Promising though Retuxin is, the cost is staggering: Treatment costs $70,000, if you can get it.

These drugs, Ampligen and Retuxin, with their hint of hope in a dark sky, raise a basic societal issue: Is it better for society to pay to make hundreds of thousands of citizens well enough to work, or is the externality of lost work too hard to figure into public health policy and budgeting?

Your tags:

TIP:

Enter the amount, and click "Tip" to submit!
Recipient's email address:
Personal message (optional):

Your email address:

Comments

Type your comment below:
Dear llewelyn King,

This article compresses my 25 plus years of living with this Silent Invisible Enemy into a one page brilliant description. Thank you for not just listening to those you interviewed, but for researching the history of this illness. Patients around the World appreciate your understanding and true compassion along with your reporting to educate the public and our federal representatives.

Thank you,
Robert Miller
Dear llewelyn King,

This article compresses my 25 plus years of living with this Silent Invisible Enemy into a one page brilliant description. Thank you for not just listening to those you interviewed, but for researching the history of this illness. Patients around the World appreciate your understanding and true compassion along with your reporting to educate the public and our federal representatives.

Thank you,
Robert Miller
Mr. King:

Thank you for reporting on this overlooked disease. There are many questions tht need to be answered, many studies yet to be done and much to be discovered before this "nut" called ME/CFS is cracked. This is perhaps the most complex, intricate and mysterious political and scientific issue I have ever known about. It is more than ME/CFS. We now have family of ME/CFS/GWI/MS/Autism/Epilepsy and Chronic Lyme Disease being tied together with evidenced based scientific proof that these are in the same family and/or strongly linked. We need help and we need it NOW. Science and journalism will not be enough; we need the third element: we are gearing up for Political Action. Thank You so much for your reportings sir. Godspeed. Julia Hugo Rachel.
Mr. King:

Thank you for reporting on this overlooked disease. There are many questions tht need to be answered, many studies yet to be done and much to be discovered before this "nut" called ME/CFS is cracked. This is perhaps the most complex, intricate and mysterious political and scientific issue I have ever known about. It is more than ME/CFS. We now have family of ME/CFS/GWI/MS/Autism/Epilepsy and Chronic Lyme Disease being tied together with evidenced based scientific proof that these are in the same family and/or strongly linked. We need help and we need it NOW. Science and journalism will not be enough; we need the third element: we are gearing up for Political Action. Thank You so much for your reportings sir. Godspeed. Julia Hugo Rachel.
Mr. King,

Thank you!
Mr. King:

Thank you for this and all your other work on behalf of those who suffer this illness. On many days I feel as though I am lying in my own coffin, but your pieces and videos are a point of light.
Thank you so much for an excellent article that summarises the silent suffering so well. Thank you for all that you do to help our cause. Thank you for this and your videos. We need all the help and support we can get. There is still so much ignorance, disbelief and lack of help for so many like myself . We suffer daily and struggle to do the most simple things in life. Our lives have been ruined and still there is nothing that really helps. It`s good news to hear about the latest results from the use of Retuxin but at that cost how many of us are ever likely to be treated? We resort to our own devices of coping with this dreadful illness. I`m dead but still living! Please continue with your wonderful work and awareness raising. Thank you.
Thank you so much for this information and your new blog!
It is unfortunate that the author did not research the history. CFS is not ME and ME should not be known as CFS. It is the misinformation and combining and misusing terms and meanings which is being promoted by these umbrella groups that has been causing most of the problems.

ME has a clearly defined disease process while CFS by definition has always been a syndrome. A syndrome (for example CFS) is defined by symptoms. A disease (such as ME) is defined by symptoms plus objective and measurable findings. Evidence based medicine requires an appropriate treatment plan which must correspond to the patients diagnosis. The mixed cohorts created by the ME/CFS rubric has caused the controversy and mystery and lack of meaningful research results. Those with a testable neurological illness will never be properly identified or treated appropriately if they are diagnosed with an unexplained symptom syndrome based on fatigue.

Only with proper diagnosis will we have any meaningful research which will provide effective treatments. We have not had effective advocacy but should expect accurate journalism.
Excellent journalism, and perfectly accurate history!
"The Chronic Fatigue Syndrome" was based on what three ME literate physicians present during the 1987 Holmes committee deliberations had identifed as "a typical outbreak of ME":
The Lake Tahoe "Raggedy Ann Illness" whose story is described in Hillary Johnson's excellent book "Osler's Web".
The CFS appellation was originally intended to be a provisional term to be used until the relationship of this illness to the Royal Free Disease / ME could be scientifically established... which seems to be taking a great deal more time than we thought.
Thank you for correcting the misinformation swirling around CFS.
I have Chronic Fatigue Immune Dysfunction Syndrome (CFS/CFIDS/ME) and HIV-NEGATIVE AIDS, idiopathic CD lymphocytopenia. With these two clinical diagnoses, I believe that makes me living proof that the AIDS-like CFS/ME is transmissible, something that the medical establishment seems unable to admit or to acknowledge. I also believe it makes me living proof that CFS and HIV-NEGATIVE AIDS are basically the same mysterious immune disorder...{more} www.cfsstraighttalk.blogspot.com